<DOC>
	<DOCNO>NCT00537043</DOCNO>
	<brief_summary>Carvedilol control release market drug treat high blood pressure . This study compare carvedilol control release carvedilol control release plus lisinopril ( fixed-dose combination ) repeat dose patient high blood pressure . This make sure carvedilol control release give lisinopril act body give alone . The study also assess safety tolerability fixed-dose combination .</brief_summary>
	<brief_title>A Study Compare COREG CR COREG CR Fixed-dose Combination Patients With High Blood Pressure</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<criteria>Inclusion criterion : Adult male females nonchild bear potential 18 60 year old . Have history mild moderate essential hypertension present mild moderate essential hypertension define Diastolic Blood Pressure &gt; /90 &lt; /109 mmHg , and/or Systolic Blood Pressure &gt; /140 &lt; /179 mmHg Body weight &gt; 60 kg ( 132 pound ) body mass index ( BMI ) 19 35 Exclusion criterion : Any clinically relevant abnormality identify screen history , physical laboratory examination , medical condition circumstance make volunteer unsuitable participation study . History advance retinopathy ( i.e. , KeithWagener Grade III IV ) Secondary form hypertension include ( limited ) coarctation aorta , primary aldosteronism , renal artery stenosis , pheochromocytoma Type 1 diabetic [ note : Type 2 diabetic HgbA1c le equal 9.0 % enrol provided Investigator considers subject clinically stable ] Signs , symptom , history congestive heart failure , angina pectoris , myocardial infarction , cerebrovascular accident , transient ischemic attack History presence clinically significant hepatic disease Liver function test ( ALT , AST , total bilirubin alkaline phosphatase ) 2 time upper limit laboratory reference range History severe pulmonary disease include asthma chronic obstructive lung disease previous history 'hypersensitivity ' Bblockers Previously treat hypertension subject , discretion Investigator , antihypertensive therapy safely withdraw study Subjects 3 antihypertensive diuretic medication [ Note : combination antihypertensive and/or diuretic product ( lisinopril hydrochlorothiazide ) consider 2 medication , dos component record . ] Subjects metabolize carvedilol poorly base CYP2D6 genotyping determine screen History regular alcohol consumption exceed 7 drinks/week woman 14 drinks/week men ( 1 drink = 5 ounce wine 12 ounce beer 1.5 ounce hard liquor ) within 6 month screen Positive urine drug screen ( UDS ) include alcohol screening . A minimum list drug screen include amphetamine , barbiturate , cocaine , opiates , cannabinoids benzodiazepine . Treatment investigational drug within 30 day five halflives , whichever longer , prior first dose study medication ( include investigational formulation market product ) Subjects receive ongoing treatment anticipated receive treatment follow medication treatment study medication : monoamine oxidase ( MAO ) inhibitor Class I III antiarrhythmic alphaadrenergic receptor blocker beta2adrenergic receptor agonist lithium Consumption grapefruit grapefruit juice within 7 day prior dose Women childbearing potential NOTE : Premenopausal female document tubal ligation hysterectomy eligible . Postmenopausal females eligible , define 12 month spontaneous amenorrhea [ questionable case blood sample simultaneous follicle stimulate hormone ( FSH ) &gt; 40 MlU/ml estradiol &lt; 40 pg/ml ( &lt; 140 pmol/L ) confirmatory ] . Resting pulse rate ≤ 50 beat per minute ( bpm ) screen QTc ≥ 450 msec ECG criterion define protocol Refusal inability discontinue use medication know inhibitors/inducers cytochrome P450 2C9 , 2D6 3A4 least 14 day 5 halflives [ ever long ] prior Day 1 Session 1 48 hour last dose study medication . [ Examples include : paroxetine , isoniazid , `` azole '' antifungal drug ( e.g . itraconazole ) , erythromycin , ticlopidine , amiodarone , quinidine , rifampin , phenobarbital ] Donation blood excess 500 mL within 56day period include estimate 210 mL blood drawn study History sensitivity carvedilol , lisinopril , alphablockers , betablockers ACE inhibitor History sensitivity heparin , heparininduced thrombocytopenia , sensitivity study medication component thereof History angioedema Positive Hepatitis B surface antigen Positive HIV Unwillingness inability follow procedure outline protocol inability provide write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>hypertension ,</keyword>
	<keyword>carvedilol ,</keyword>
	<keyword>repeat-dosing</keyword>
</DOC>